# Pharmaceutical Technology > Pharmaceutical Technology - Healthcare Publication - Base URL: https://www.pharmtech.com - Generated: 2026-10-20T18:01:16.207Z - Content updates: multiple times daily ## Content Access for AI Agents This site supports content negotiation for AI/LLM consumption. Request any article URL with an appropriate Accept header to receive structured content instead of HTML. **Supported content types:** - `text/markdown` — Clean Markdown with YAML frontmatter - `text/plain` — Plain text (same as Markdown) - `text/html` — Default HTML response **Example request:** ``` curl -H "Accept: text/markdown" https://www.pharmtech.com/view/article-slug ``` **YAML frontmatter schema** (returned with every Markdown response): | Field | Type | Description | |-------|------|-------------| | `title` | string | Article headline | | `description` | string | Summary/excerpt (max 300 chars) | | `url` | string | Canonical article URL | | `canonical_url` | string | Canonical URL if different from `url` | | `published` | ISO 8601 | Original publication date | | `modified` | ISO 8601 | Last modification date | | `authors` | string[] | Author display names | | `content_type` | string | Content category (e.g., "News", "Clinical") | | `categories` | string[] | Taxonomy categories | | `tags` | string[] | SEO tags | | `image` | string | Featured image URL | | `publisher` | string | Publication/site name | **Discovery headers** (included on all responses): - `Link: ; rel="llms"` — RFC 8288 link to this file - `X-Llms-Txt: https://www.pharmtech.com/llms.txt` — Explicit discovery header ## Usage Policy - Robots policy: [https://www.pharmtech.com/robots.txt](https://www.pharmtech.com/robots.txt) - Cache behavior: responses are cached for ~5 minutes (max-age=300, stale-while-revalidate=329) - Rate guidance: prefer RSS and sitemap feeds over crawling individual pages - Attribution: All content © MJH Life Sciences. Include source URLs when citing. ## Content Categories - [AI Pulse Check](https://www.pharmtech.com/ai-pulse-check) - [Behind the Headlines](https://www.pharmtech.com/behind-the-headlines) - [Bio/Pharma Business](https://www.pharmtech.com/bio-pharma business) - [Business](https://www.pharmtech.com/business) - [Business Features](https://www.pharmtech.com/business-features) - [Drug Digest](https://www.pharmtech.com/drug-digest) - [Drug Solutions Podcast](https://www.pharmtech.com/drug-solutions-podcast) - [Events](https://www.pharmtech.com/events) - [ICH Q9(R1) Review e-Book](https://www.pharmtech.com/ich-q9r1-review-e-book) - [No AD Display Please](https://www.pharmtech.com/no-ad-display-please) - [Peer-Reviewed Research](https://www.pharmtech.com/peer-reviewed-research) - [PharmTech News](https://www.pharmtech.com/news) - [PharmTech Products](https://www.pharmtech.com/pharmtech-products) - [PharmTech Videos](https://www.pharmtech.com/pharmtech-videos) - [Sponsored Podcasts](https://www.pharmtech.com/sponsored-podcasts) - [Sponsored Resources](https://www.pharmtech.com/sponsored-resources) - [Sponsored Videos](https://www.pharmtech.com/sponsored-videos) - [Tech Talk](https://www.pharmtech.com/pharmtech-talk) - [Topic](https://www.pharmtech.com/topic) - [Video Series](https://www.pharmtech.com/video-series) - [Webcasts](https://www.pharmtech.com/webcasts) - [Whitepapers](https://www.pharmtech.com/whitepapers) ## Featured Content - [AAPS PharmSci 360 2026: System Suitability Standards in E&L Testing](https://www.pharmtech.com/view/aaps-pharmsci-360-2026-system-suitability-standards-in-e-l-testing): Ravi Kiran Kaja, PhD, explains how USP’s industry-wide initiative aims to build confidence in trace-level extractables and leachables results. - [Drug-Device Combination Apps: The FDA's 3 Questions for Sponsors](https://www.pharmtech.com/view/drug-device-combination-apps-fda-3-questions-for-sponsors): FDA final guidance defines when companion app output counts as drug labeling and when device-connected or standalone apps belong in prescribing inform... - [Sustainability in Healthcare Packaging: The Journey From Yesterday to Tomorrow](https://www.pharmtech.com/view/sustainability-in-healthcare-packaging-the-journey-from-yesterday-to-tomorrow): Science, circularity, regulation, and technology are reshaping how the industry develops packaging for medicines. - [Quotient Sciences Translational Pharmaceutics ](https://www.pharmtech.com/view/quotient-sciences-translational-pharmaceutics): Early-phase drug development often stalls when development, manufacturing, and clinical activities operate independently. Learn how an integrated m... - [AI-enhanced formulation development with Translational Pharmaceutics®](https://www.pharmtech.com/view/ai-enhanced-formulation-development-with-translational-pharmaceutics-): Formulate the right drug product, faster and with a higher probability of success: Quotient Sciences’ new proprietary AI solution combines our insigh... - [PharmTech AI Pulse Check: SURPASS and the Case for Simulation-Based Trials](https://www.pharmtech.com/view/pharmtech-ai-pulse-check-surpass-case-for-simulation-based-trials): Panelists on PharmTech AI Pulse Check debate SURPASS, a new digital-twin trial program, regulatory acceptance, and the data-cleanup burden it will cre... - [Three Targeted Delivery Deals: What CMC Teams Should Watch](https://www.pharmtech.com/view/three-targeted-delivery-deals-what-cmc-teams-should-watch): Roche-Hansoh, Merck KGaA-Silence, and Lilly-METiS deals show how ADCs, siRNA, and lipid nanoparticles reshape demands on CMC and manufacturing teams. - [Germany’s Medical Biotechnology Sector is Flourishing](https://www.pharmtech.com/view/germany-s-medical-biotechnology-sector-is-flourishing): Germany is home to several prominent pharma companies and more than 1000 innovative biotechs. - [Expedited IND Pilot Targets Sequential Delays Slowing First-in-Human Trials](https://www.pharmtech.com/view/expedited-ind-pilot-targets-sequential-delays-slowing-first-in-human-trials): Boyang Wang of Immortal Dragons explains how FDA's Expedited IND Pilot and QRIs could compress sequential first-in-human steps as China's Decree 818 r... - [PharmTech AI Pulse Check: Why Pharma Should Weigh In on FDA's Generative AI Paper](https://www.pharmtech.com/view/pharmtech-ai-pulse-check-why-pharma-should-weigh-in-on-fdas-generative-ai-paper): The deadline to comment on FDA's generative AI paper is Oct 19, 2026. We explain why professionals in pharma manufacturing should weigh in. ## Feeds and Indexes - [RSS Feed](https://www.pharmtech.com/rss.xml): Latest articles in XML syndication format - [Sitemap](https://www.pharmtech.com/sitemap.xml): Complete URL index for all published pages - [News Sitemap](https://www.pharmtech.com/sitemap-news.xml): Recent articles optimized for news indexing - [Authors Directory](https://www.pharmtech.com/authors): Browse all contributors and their published work